Status:
COMPLETED
Prospective Cohort Study to Describe the Clinical Characteristics of COVID-19, the Acquired Immune Response and the Biological and Clinical Parameters of Patients Followed in Oncology by the Saint-Joseph Hospital Group for a Period of 6 Months During the COVID-19 Pandemic
Lead Sponsor:
Fondation Hôpital Saint-Joseph
Collaborating Sponsors:
ObvioHealth
Conditions:
Oncology
COVID-19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This registry will allow to evaluate the correlation of the incidence and evolution of associated symptoms of infection of COVID-19 with the biological and clinical parameters in patients followed in ...
Detailed Description
Prior to conducting any of the screening tests, the Investigator or his designee will explain the trial fully to the prospective patient and provide him with a copy of the Patient Information Leaflet/...
Eligibility Criteria
Inclusion
- Patient over 18 years of age
- Patient followed in the medical oncology department of Paris Saint-Joseph Hospital Paris in France
- Patient Having regular access to smartphone and internet sufficient to support study demands
- French-speaking patient
- Affiliation to the social security network
- Willing and able to provide given oral, free, informed and express consent
Exclusion
- Patients unable or unwilling to perform all requested study tasks
- Patient under tutorship or curatorship
- Patient deprived of liberty
- Pregnant or lactating patient
Key Trial Info
Start Date :
June 29 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 3 2022
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT04437719
Start Date
June 29 2020
End Date
June 3 2022
Last Update
June 30 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Paris Saint-Joseph
Paris, France, 75014